Cargando…
Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil
Objectives: The aim of this study is to evaluate some mechanisms of the immune response of people infected with SARS-CoV-2 in both acute infection and early and late convalescence phases. Methods: This is a cohort study of 70 cases of COVID-19, confirmed by RT-PCR, followed up to 60 days. Plasma Sam...
Autores principales: | Pacheco, Vanessa, Cuber Guimarães, Rosane, Corrêa-Moreira, Danielly, Magalhães, Carlos Eduardo, Figueiredo, Douglas, Guttmann, Patricia, Trindade, Gisela Freitas, da Silva, Juliana Fernandes Amorim, Ano Bom, Ana Paula Dinis, de Lourdes Maia, Maria, Melgaço, Juliana Gil, da Costa Barros, Tamiris Azamor, da Silva, Andrea Marques Vieira, Oliveira, Manoel Marques Evangelista |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385121/ https://www.ncbi.nlm.nih.gov/pubmed/37515295 http://dx.doi.org/10.3390/v15071609 |
Ejemplares similares
-
Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?
por: Melgaço, Juliana Gil, et al.
Publicado: (2020) -
Impairment of CD4+ T and Memory B Cell Responses but Normal Memory CD8+T-Cell Activation on Crohn’s Disease after COVID-19 Vaccination: A Twin Case
por: Melgaço, Fabiana Gil, et al.
Publicado: (2021) -
Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs
por: Melgaço, Juliana Gil, et al.
Publicado: (2020) -
Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug
por: de Brito e Cunha, Danielle, et al.
Publicado: (2022) -
Activation of an Effective Immune Response after Yellow Fever Vaccination Is Associated with the Genetic Background and Early Response of IFN-γ and CLEC5A
por: Azamor, Tamiris, et al.
Publicado: (2021)